Product NDC: | 0378-0211 |
Proprietary Name: | Chlordiazepoxide and Amitriptyline Hydrochloride |
Non Proprietary Name: | chlordiazepoxide and amitriptyline hydrochloride |
Active Ingredient(s): | 12.5; 5 mg/1; mg/1 & nbsp; chlordiazepoxide and amitriptyline hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0378-0211 |
Labeler Name: | Mylan Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA071297 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100127 |
Package NDC: | 0378-0211-01 |
Package Description: | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-0211-01) |
NDC Code | 0378-0211-01 |
Proprietary Name | Chlordiazepoxide and Amitriptyline Hydrochloride |
Package Description | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-0211-01) |
Product NDC | 0378-0211 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | chlordiazepoxide and amitriptyline hydrochloride |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20100127 |
Marketing Category Name | ANDA |
Labeler Name | Mylan Pharmaceuticals Inc. |
Substance Name | AMITRIPTYLINE HYDROCHLORIDE; CHLORDIAZEPOXIDE |
Strength Number | 12.5; 5 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient],Tricyclic Antidepressant [EPC] |